Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Mini-Review Article

Tuberculosis and Diabetes Mellitus Co-morbidity

Author(s): Degtyareva Svetlana*, Olga Vinokurova and Vera Zimina

Volume 18, Issue 4, 2022

Published on: 08 November, 2021

Page: [233 - 240] Pages: 8

DOI: 10.2174/1573398X17666210917125937

Price: $65

Abstract

Tuberculosis (TB) and Diabetes Mellitus (DM) association poses the re-emerging problem nowadays and challenge on the way towards a tuberculosis-free world. There are some peculiarities in the immune function of DM patients, which make them more susceptible to infections, including TB. This results in a higher prevalence of TB among DM patients (OR=1.15 according to the last meta-analysis). Clinical manifestations of DM/TB often differ from the classical course of the disease - these patients are more frequently symptomatic, more inclined to cavitary disease and, according to some data, to lower lobe involvement. Data on multi-drug resistance prevalence among DM/TB patients are controversial and need further research, especially in terms of primary resistance. Higher frequency of adverse reactions, slower sputum conversion and foci regression make treatment in this population more difficult and worsen outcomes. Potential measures to lower the burden of co-morbidity are: new treatment regimens, bi-directional screening, proper DM managing and controlling, testing for latent tuberculosis infection and its treatment, and new vaccines development. Feasibility and efficacy of these measures are to be investigated in the context of settings with different DM and TB prevalence and available resources.

Keywords: Tuberculosis, diabetes, epidemiology, clinical, prevention, public health.

Graphical Abstract
[1]
World Health Organization. Global tuberculosis report 2020. 2020.
[2]
Viswanathan, V.; Kumpatla, S.; Aravindalochanan, V.; Rajan, R.; Chinnasamy, C.; Srinivasan, R.; Selvam, J.M.; Kapur, A. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One, 2012, 7(7), e41367.
[http://dx.doi.org/10.1371/journal.pone.0041367] [PMID: 22848473]
[3]
Jiménez-Corona, M.E.; Cruz-Hervert, L.P.; García-García, L.; Ferreyra-Reyes, L.; Delgado-Sánchez, G.; Bobadilla-Del-Valle, M.; Canizales-Quintero, S.; Ferreira-Guerrero, E.; Báez-Saldaña, R.; Téllez-Vázquez, N.; Montero-Campos, R.; Mongua-Rodriguez, N.; Martínez-Gamboa, R.A.; Sifuentes-Osornio, J.; Ponce-de-León, A. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax, 2013, 68(3), 214-220.
[http://dx.doi.org/10.1136/thoraxjnl-2012-201756] [PMID: 23250998]
[4]
Reis-Santos, B.; Locatelli, R.; Horta, B.L.; Faerstein, E.; Sanchez, M.N.; Riley, L.W.; Maciel, E.L. Socio-demographic and clinical differences in subjects with tuberculosis with and without diabetes mellitus in Brazil-a multivariate analysis. PLoS One, 2013, 8(4), e62604.
[http://dx.doi.org/10.1371/journal.pone.0062604] [PMID: 23638123]
[5]
Workneh, M.H.; Bjune, G.A.; Yimer, S.A. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS One, 2017, 12(4), e0175925.
[http://dx.doi.org/10.1371/journal.pone.0175925] [PMID: 28430796]
[6]
Noubiap, J.J.; Nansseu, J.R.; Nyaga, U.F.; Nkeck, J.R.; Endomba, F.T.; Kaze, A.D.; Agbor, V.N.; Bigna, J.J. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob. Health, 2019, 7(4), e448-e460.
[http://dx.doi.org/10.1016/S2214-109X(18)30487-X] [PMID: 30819531]
[7]
Alkabab YM, Al-abdely HM, Heysell SK, Arabia S, et al. Diabetes-related tuberculosis in the Middle East: an urgent need for regional research Yosra. Int J Infect Dis, 2016, 64-70.
[http://dx.doi.org/10.1016/j.ijid.2015.09.010.Diabetes-related]
[8]
Lucenko, I.; Riekstina, V.; Perevoscikovs, J.; Mozgis, D.; Khogali, M.; Gadoev, J.; de Colombani, P.; Kumar, A.M. Treatment outcomes among drug-susceptible tuberculosis patients in Latvia, 2006-2010. Public Health Action, 2014, 4(Suppl. 2), S54-S58.
[http://dx.doi.org/10.5588/pha.14.0040] [PMID: 26393099]
[9]
Nasa, J.N.; Brostrom, R.; Ram, S.; Kumar, A.M.V.; Seremai, J.; Hauma, M.; Paul, I.A.; Langidrik, J.R. Screening adult tuberculosis patients for diabetes mellitus in Ebeye, Republic of the Marshall Islands. Public Health Action, 2014, 4(Suppl. 1), S50-S52.
[http://dx.doi.org/10.5588/pha.13.0079] [PMID: 26477288]
[10]
Moreno-Martínez, A.; Casals, M.; Orcau, À.; Gorrindo, P.; Masdeu, E.; Caylà, J.A. Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013. Int. J. Tuberc. Lung Dis., 2015, 19(12), 1507-1512.
[http://dx.doi.org/10.5588/ijtld.15.0102] [PMID: 26614193]
[11]
Lin, Y.H.; Chen, C.P.; Chen, P.Y.; Huang, J.C.; Ho, C.; Weng, H.H.; Tsai, Y.H.; Peng, Y.S. Screening for pulmonary tuberculosis in type 2 diabetes elderly: a cross-sectional study in a community hospital. BMC Public Health, 2015, 15, 3.
[http://dx.doi.org/10.1186/1471-2458-15-3] [PMID: 25572102]
[12]
Amin, S.; Khattak, M.I.; Shabbier, G.W.M. Frequency of pulmonary tuberculosis in patients with diabetes mellitus. Gomal J Med Sci, 2011, 9, 163-166.
[http://dx.doi.org/10.1159/000050578]
[13]
Berkowitz, N.; Okorie, A.; Goliath, R.; Levitt, N.; Wilkinson, R.J.; Oni, T. The prevalence and determinants of active tuberculosis among diabetes patients in Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Res. Clin. Pract., 2018, 138, 16-25.
[http://dx.doi.org/10.1016/j.diabres.2018.01.018] [PMID: 29382589]
[14]
Dabhi, P.A.; Thangakunam, B.; Gupta, R.; James, P.; Thomas, N.; Naik, D.; Christopher, D.J. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital. PLoS One, 2020, 15(6), e0233385.
[http://dx.doi.org/10.1371/journal.pone.0233385] [PMID: 32502176]
[15]
Nair, A.; Guleria, R.; Kandasamy, D.; Sharma, R.; Tandon, N.; Singh, U.B.; Goswami, R. Prevalence of pulmonary tuberculosis in young adult patients with Type 1 diabetes mellitus in India. Multidiscip. Respir. Med., 2016, 11, 22.
[http://dx.doi.org/10.1186/s40248-016-0058-z] [PMID: 27168934]
[16]
Webb, E.A.; Hesseling, A.C.; Schaaf, H.S.; Gie, R.P.; Lombard, C.J.; Spitaels, A.; Delport, S.; Marais, B.J.; Donald, K.; Hindmarsh, P.; Beyers, N. High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus. Int. J. Tuberc. Lung Dis., 2009, 13(7), 868-874.
[PMID: 19555537]
[17]
Hayashi, S.; Chandramohan, D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop. Med. Int. Health, 2018, 23(10), 1058-1070.
[http://dx.doi.org/10.1111/tmi.13133] [PMID: 30062731]
[18]
Al-Rifai, R.H.; Pearson, F.; Critchley, J.A.; Abu-Raddad, L.J. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11), e0187967.
[http://dx.doi.org/10.1371/journal.pone.0187967] [PMID: 29161276]
[19]
Jeon, C.Y.; Murray, M.B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med., 2008, 5(7), e152.
[http://dx.doi.org/10.1371/journal.pmed.0050152] [PMID: 18630984]
[20]
Critchley, J.A.; Carey, I.M.; Harris, T.; DeWilde, S.; Hosking, F.J.; Cook, D.G. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care, 2018, 41(10), 2127-2135.
[http://dx.doi.org/10.2337/dc18-0287] [PMID: 30104296]
[21]
Ponce-De-Leon, A.; Garcia-Garcia Md, Mde.L.; Garcia-Sancho, M.C.; Gomez-Perez, F.J.; Valdespino-Gomez, J.L.; Olaiz-Fernandez, G.; Rojas, R.; Ferreyra-Reyes, L.; Cano-Arellano, B.; Bobadilla, M.; Small, P.M.; Sifuentes-Osornio, J. Tuberculosis and diabetes in southern Mexico. Diabetes Care, 2004, 27(7), 1584-1590.
[http://dx.doi.org/10.2337/diacare.27.7.1584] [PMID: 15220232]
[22]
Martinez, N.; Kornfeld, H. Diabetes and immunity to tuberculosis. Eur. J. Immunol., 2014, 44(3), 617-626.
[http://dx.doi.org/10.1002/eji.201344301] [PMID: 24448841]
[23]
Gomez, D.I.; Twahirwa, M. S. SL, I. RB. Reduced association of mycobacterium with monocytes from diabetes patients with poor glucose control. Tuberc, 2013, 93, 192-197.
[http://dx.doi.org/10.1016/j.tube.2012.10.003] [PMID: 23131496]
[24]
Restrepo, B.I.; Twahirwa, M.; Rahbar, M.H.; Schlesinger, L.S. Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. PLoS One, 2014, 9(3), e92977.
[http://dx.doi.org/10.1371/journal.pone.0092977] [PMID: 24671137]
[25]
Ayelign, B.; Negash, M.; Genetu, M.; Wondmagegn, T.; Shibabaw, T. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis. J. Immunol. Res., 2019, 2019, 6196532.
[http://dx.doi.org/10.1155/2019/6196532] [PMID: 31583258]
[26]
Lee, M.R.; Huang, Y.P.; Kuo, Y.T.; Luo, C.H.; Shih, Y.J.; Shu, C.C.; Wang, J.Y.; Ko, J.C.; Yu, C.J.; Lin, H.H. Diabetes mellitus and latent tuberculosis infection: a systematic review and metaanalysis. Clin. Infect. Dis., 2017, 64(6), 719-727.
[http://dx.doi.org/10.1093/cid/ciw836] [PMID: 27986673]
[27]
Blanco-Guillot, F.; Delgado-Sánchez, G.; Mongua-Rodríguez, N.; Cruz-Hervert, P.; Ferreyra-Reyes, L.; Ferreira-Guerrero, E.; Yanes-Lane, M.; Montero-Campos, R.; Bobadilla-Del-Valle, M.; Torres-González, P.; Ponce-de-León, A.; Sifuentes-Osornio, J.; Garcia-Garcia, L. Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(9), e0184675.
[http://dx.doi.org/10.1371/journal.pone.0184675] [PMID: 28902922]
[28]
Kumar, N.P.; Sridhar, R.; Banurekha, V.V.; Jawahar, M.S.; Nutman, T.B.; Babu, S. Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J. Infect. Dis., 2013, 208(5), 739-748.
[http://dx.doi.org/10.1093/infdis/jit241] [PMID: 23715661]
[29]
Restrepo, B.I.; Fisher-Hoch, S.P.; Pino, P.A.; Salinas, A.; Rahbar, M.H.; Mora, F.; Cortes-Penfield, N.; McCormick, J.B. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin. Infect. Dis., 2008, 47(5), 634-641.
[http://dx.doi.org/10.1086/590565] [PMID: 18652554]
[30]
Stalenhoef, J.E.; Alisjahbana, B.; Nelwan, E.J.; van der Ven-Jongekrijg, J.; Ottenhoff, T.H.M.; van der Meer, J.W.M.; Nelwan, R.H.; Netea, M.G.; van Crevel, R. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur. J. Clin. Microbiol. Infect. Dis., 2008, 27(2), 97-103.
[http://dx.doi.org/10.1007/s10096-007-0395-0] [PMID: 17962984]
[31]
Al-Attiyah, R.J.; Mustafa, A.S. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)- vaccinated healthy subjects. Clin. Exp. Immunol., 2009, 158(1), 64-73.
[http://dx.doi.org/10.1111/j.1365-2249.2009.04000.x] [PMID: 19737232]
[32]
Boillat-Blanco, N.; Tumbo, A.N.; Perreau, M.; Amelio, P.; Ramaiya, K.L.; Mganga, M.; Schindler, C.; Gagneux, S.; Reither, K.; Probst-Hensch, N.; Pantaleo, G.; Daubenberger, C.; Portevin, D. Hyperglycaemia is inversely correlated with live M. bovis BCG-specific CD4+ T cell responses in Tanzanian adults with latent or active tuberculosis. Immun. Inflamm. Dis., 2018, 6(2), 345-353.https://doi.org/https://dx.doi.org/10.1002/iid3.222
[http://dx.doi.org/10.1002/iid3.222] [PMID: 29642283]
[33]
Meenakshi, P.; Ramya, S.; Lavanya, J.; Vijayalakshmi, V.; Sumanlatha, G. Effect of IFN-γ, IL-12 and IL-10 cytokine production and mRNA expression in tuberculosis patients with diabetes mellitus and their household contacts. Cytokine, 2016, 81, 127-136.
[http://dx.doi.org/10.1016/j.cyto.2016.03.009] [PMID: 27002606]
[34]
Lachmandas, E.; Thiem, K.; van den Heuvel, C.; Hijmans, A.; de Galan, B.E.; Tack, C.J.; Netea, M.G.; van Crevel, R.; van Diepen, J.A. Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis., 2018, 37(2), 371-380.
[http://dx.doi.org/10.1007/s10096-017-3145-y] [PMID: 29189980]
[35]
Kumar, N.P.; Moideen, K.; George, P.J.; Dolla, C.; Kumaran, P.; Babu, S. Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent manner. Eur. J. Immunol., 2016, 46(2), 390-399.
[http://dx.doi.org/10.1002/eji.201545973] [PMID: 26518995]
[36]
Hodgson, K.; Morris, J.; Bridson, T.; Govan, B.; Rush, C.; Ketheesan, N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology, 2015, 144(2), 171-185.
[http://dx.doi.org/10.1111/imm.12394] [PMID: 25262977]
[37]
Zhong, H.; Magee, M.J.; Huang, Y.; Hui, Q.; Gwinn, M.; Gandhi, N.R.; Sun, Y.V. Evaluation of the host genetic effects of tuberculosis-associated variants among patients with type 1 and type 2 diabetes mellitus. Open Forum Infect. Dis., 2020, 7(4), a106.
[http://dx.doi.org/10.1093/ofid/ofaa106] [PMID: 32328508]
[38]
Sane Schepisi, M.; Navarra, A.; Altet Gomez, M.N.; Dudnyk, A.; Dyrhol-Riise, A.M.; Esteban, J.; Giorgetti, P.F.; Gualano, G.; Guglielmetti, L.; Heyckendorf, J.; Kaluzhenina, A.; Lange, B.; Lange, C.; Manika, K.; Miah, J.; Nanovic, Z.; Pontali, E.; Prego, M.R.; Solovic, I.; Tiberi, S.; Palmieri, F.; Girardi, E. Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infect. Dis., 2018, 6(1), ofy337.
[http://dx.doi.org/10.1093/ofid/ofy337] [PMID: 30697572]
[39]
Restrepo BI, Kleynhans L, Salinas BA, et al. Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups. Tuberculosis (Edinb) 2018;113:10-18.
[http://dx.doi.org/10.1007/978-3-319-97367-8_1] [PMID: 30514492]
[40]
Zafar, M.I.; Chen, L-L.; Xiaofeng, Y.; Gao, F. Impact of diabetes mellitus on radiological presentation of pulmonary tuberculosis in otherwise non-immunocompromised patients: a systematic review. Curr. Med. Imaging Rev., 2019, 15(6), 543-554.
[http://dx.doi.org/10.2174/1573405614666180806124416] [PMID: 32008562]
[41]
Chiang, C.Y.; Lee, J.J.; Chien, S.T.; Enarson, D.A.; Chang, Y.C.; Chen, Y.T.; Hu, T.Y.; Lin, C.B.; Suk, C.W.; Tao, J.M.; Bai, K.J. Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One, 2014, 9(4), e93397.
[http://dx.doi.org/10.1371/journal.pone.0093397] [PMID: 24699457]
[42]
Chang, J.T.; Dou, H.Y.; Yen, C.L.; Wu, Y.H.; Huang, R.M.; Lin, H.J.; Su, I.J.; Shieh, C.C. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J. Formos. Med. Assoc., 2011, 110(6), 372-381.
[http://dx.doi.org/10.1016/S0929-6646(11)60055-7] [PMID: 21741005]
[43]
Kumar P, Fukutani N, Shruthi FK, Alves B. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. Elife 2019; 8: e46477.
[44]
Pang, Y.; An, J.; Shu, W.; Huo, F.; Chu, N.; Gao, M.; Qin, S.; Huang, H.; Chen, X.; Xu, S. Epidemiology of extrapulmonary tuberculosis among inpatients, China, 2008-2017. Emerg. Infect. Dis., 2019, 25(3), 457-464.
[http://dx.doi.org/10.3201/eid2503.180572] [PMID: 30789144]
[45]
Lin, J.N.; Lai, C.H.; Chen, Y.H.; Lee, S.S.J.; Tsai, S.S.; Huang, C.K.; Chung, H.C.; Liang, S.H.; Lin, H.H. Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int. J. Tuberc. Lung Dis., 2009, 13(5), 620-625.
[PMID: 19383196]
[46]
Gomes, T.; Reis-Santos, B.; Bertolde, A.; Johnson, J.L.; Riley, L.W.; Maciel, E.L. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect. Dis., 2014, 14, 9.
[http://dx.doi.org/10.1186/1471-2334-14-9] [PMID: 24400848]
[47]
Magee, M.J.; Foote, M.; Ray, S.M.; Gandhi, N.R.; Kempker, R.R. Diabetes mellitus and extrapulmonary tuberculosis: site distribution and risk of mortality. Epidemiol. Infect., 2016, 144(10), 2209-2216.
[http://dx.doi.org/10.1017/S0950268816000364] [PMID: 26926092]
[48]
Cadena, J.; Rathinavelu, S.; Lopez-Alvarenga, J.C.; Restrepo, B.I. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries. Tuberculosis (Edinb.), 2019, 116S, S89-S97.
[http://dx.doi.org/10.1016/j.tube.2019.04.015] [PMID: 31085129]
[49]
Magee, M.J.; Salindri, A.D.; Kyaw, N.T.T.; Auld, S.C.; Haw, J.S.; Umpierrez, G.E. Stress hyperglycemia in patients with tuberculosis disease: epidemiology and clinical implications. Curr. Diab. Rep., 2018, 18(9), 71.
[http://dx.doi.org/10.1007/s11892-018-1036-y] [PMID: 30090969]
[50]
Boillat-Blanco, N.; Ramaiya, K.L.; Mganga, M.; Minja, L.T.; Bovet, P.; Schindler, C.; Von Eckardstein, A.; Gagneux, S.; Daubenberger, C.; Reither, K.; Probst-Hensch, N. Transient hyperglycemia in patients with tuberculosis in Tanzania: Implications for diabetes screening algorithms. J. Infect. Dis., 2016, 213(7), 1163-1172.
[http://dx.doi.org/10.1093/infdis/jiv568] [PMID: 26609005]
[51]
Tabarsi, P.; Baghaei, P.; Marjani, M.; Vollmer, W.M.; Masjedi, M.R.; Harries, A.D. Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study. J. Diabetes Metab. Disord., 2014, 13(1), 123.
[http://dx.doi.org/10.1186/s40200-014-0123-0] [PMID: 25551103]
[52]
Aftab, H.; Christensen, D.L.; Ambreen, A.; Jamil, M.; Garred, P.; Petersen, J.H.; Nielsen, S.D.; Bygbjerg, I.C. Tuberculosis-related diabetes: is it reversible after complete treatment? Am. J. Trop. Med. Hyg., 2017, 97(4), 1099-1102.
[http://dx.doi.org/10.4269/ajtmh.16-0816] [PMID: 28820679]
[53]
Menon, S.; Rossi, R.; Dusabimana, A.; Zdraveska, N.; Bhattacharyya, S.; Francis, J. The epidemiology of tuberculosis-associated hyperglycemia in individuals newly screened for type 2 diabetes mellitus: systematic review and meta-analysis. BMC Infect. Dis., 2020, 20(1), 937.
[http://dx.doi.org/10.1186/s12879-020-05512-7] [PMID: 33297969]
[54]
Song, W.M.; Shao, Y.; Liu, J.Y.; Tao, N.N.; Liu, Y.; Zhang, Q.Y.; Xu, T.T.; Li, S.J.; Yu, C.B.; Gao, L.; Cui, L.L.; Li, Y.F.; Li, H.C. Primary drug resistance among tuberculosis patients with diabetes mellitus: a retrospective study among 7223 cases in China. Infect. Drug Resist., 2019, 12, 2397-2407.
[http://dx.doi.org/10.2147/IDR.S217044] [PMID: 31447568]
[55]
Rumende, C.M. Risk factors for multidrug-resistant tuberculosis. Acta Med. Indones., 2018, 50(1), 1-2.
[PMID: 29686169]
[56]
Evangelista, M.D.S.N.; Maia, R.; Toledo, J.P.; Abreu, R.G.; Barreira, D. Tuberculosis associated with diabetes mellitus by age group in Brazil: a retrospective cohort study, 2007-2014. Braz. J. Infect. Dis., 2020, 24(2), 130-136.
[http://dx.doi.org/10.1016/j.bjid.2020.03.005] [PMID: 32298639]
[57]
Liu, Q.; Li, W.; Xue, M.; Chen, Y.; Du, X.; Wang, C.; Han, L.; Tang, Y.; Feng, Y.; Tao, C.; He, J.Q. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci. Rep., 2017, 7(1), 1090.
[http://dx.doi.org/10.1038/s41598-017-01213-5] [PMID: 28439071]
[58]
Tegegne, B.S.; Mengesha, M.M.; Teferra, A.A.; Awoke, M.A.; Habtewold, T.D. Association between diabetes mellitus and multi- drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst. Rev., 2018, 7(1), 161.
[http://dx.doi.org/10.1186/s13643-018-0828-0] [PMID: 30322409]
[59]
Huang, D.; Wang, Y.; Wang, Y.; Liang, Z. The impact of diabetes mellitus on drug resistance in patients with newly diagnosed tuberculosis: a systematic review and meta-analysis. Ann. Palliat. Med., 2020, 9(2), 152-162.
[http://dx.doi.org/10.21037/apm.2020.02.16] [PMID: 32268768]
[60]
Huangfu, P.; Ugarte-Gil, C.; Golub, J.; Pearson, F.; Critchley, J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis., 2019, 23(7), 783-796.
[http://dx.doi.org/10.5588/ijtld.18.0433] [PMID: 31439109]
[61]
Baker, M.A.; Harries, A.D.; Jeon, C.Y.; Hart, J.E.; Kapur, A.; Lönnroth, K.; Ottmani, S.E.; Goonesekera, S.D.; Murray, M.B. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med., 2011, 9, 81.
[http://dx.doi.org/10.1186/1741-7015-9-81] [PMID: 21722362]
[62]
Gil-Santana, L.; Almeida-Junior, J.L.; Oliveira, C.A.M.; Hickson, L.S.; Daltro, C.; Castro, S.; Kornfeld, H.; Netto, E.M.; Andrade, B.B. Diabetes is associated with worse clinical presentation in tuberculosis patients from brazil: a retrospective cohort study. PLoS One, 2016, 11(1), e0146876.
[63]
Samuels, J.P.; Sood, A.; Campbell, J.R.; Ahmad Khan, F.; Johnston, J.C. Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis. Sci. Rep., 2018, 8(1), 4980.
[http://dx.doi.org/10.1038/s41598-018-23344-z] [PMID: 29563561]
[64]
Menon, S.; Rossi, R.; Nshimyumukiza, L.; Wusiman, A.; Zdraveska, N.; Eldin, M.S. Convergence of a diabetes mellitus, protein energy malnutrition, and TB epidemic: the neglected elderly population. BMC Infect. Dis., 2016, 16, 361.
[http://dx.doi.org/10.1186/s12879-016-1718-5] [PMID: 27456231]
[65]
van Crevel, R.; Koesoemadinata, R.; Hill, P.C.; Harries, A.D. Clinical management of combined tuberculosis and diabetes. Int. J. Tuberc. Lung Dis., 2018, 22(12), 1404-1410.
[http://dx.doi.org/10.5588/ijtld.18.0340] [PMID: 30606312]
[66]
Song, C.; Xie, W.; Gong, L.; Ren, M.; Pan, P.; Luo, B. The relationship between HbA1c control levels and antituberculosis treatment effects: a meta-analysis. J. Chin. Med. Assoc., 2019, 82(12), 915-921.
[http://dx.doi.org/10.1097/JCMA.0000000000000205] [PMID: 31800532]
[67]
World Health Organization.WHO consolidated guidelines on drug-resistant tuberculosis treatment; Geneva, 2019.
[68]
World Health Organization.Collaborative framework for care and control of tuberculosis and diabetes; Geneva, 2011.
[69]
(RNTCP) RNTCP. National framework for joint TB-Diabetes collaborative activities. 2017.
[70]
Castellanos-Joya, M.; Delgado-Sánchez, G.; Ferreyra-Reyes, L.; Cruz-Hervert, P.; Ferreira-Guerrero, E.; Ortiz-Solís, G.; Jiménez, M.I.; Salazar, L.L.; Montero-Campos, R.; Mongua-Rodríguez, N.; Baez-Saldaña, R.; Bobadilla-del-Valle, M.; González-Roldán, J.F.; Ponce-de-León, A.; Sifuentes-Osornio, J.; García-García, L. Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS One, 2014, 9(9), e106961.
[http://dx.doi.org/10.1371/journal.pone.0106961] [PMID: 25229236]
[71]
Kyaw Soe, T.; Soe, K.T.; Satyanarayana, S.; Saw, S.; San, C.C.; Aung, S.T. Gaps in implementing bidirectional screening for tuberculosis and diabetes mellitus in Myanmar: An operational research study. Trop. Med. Infect. Dis., 2020, 5(1), E19.
[http://dx.doi.org/10.3390/tropicalmed5010019] [PMID: 32024081]
[72]
Viney, K.; Cavanaugh, J.; Kienene, T.; Harley, D.; Kelly, P.M.; Sleigh, A.; O’Connor, J.; Mase, S. Tuberculosis and diabetes mellitus in the Republic of Kiribati: a case-control study. Trop. Med. Int. Health, 2015, 20(5), 650-657.
[http://dx.doi.org/10.1111/tmi.12462] [PMID: 25598275]
[73]
Basir, M.S.; Habib, S.S.; Zaidi, S.M.A.; Khowaja, S.; Hussain, H.; Ferrand, R.A.; Khan, A.J. Operationalization of bi-directional screening for tuberculosis and diabetes in private sector healthcare clinics in Karachi, Pakistan. BMC Health Serv. Res., 2019, 19(1), 147.
[http://dx.doi.org/10.1186/s12913-019-3975-7] [PMID: 30841929]
[74]
Salifu, R.S.; Hlongwana, K.W. Barriers and facilitators to bidirectional screening of TB-DM in Ghana: Healthcare workers’ perspectives. PLoS One, 2020, 15(7), e0235914.
[http://dx.doi.org/10.1371/journal.pone.0235914] [PMID: 32663233]
[75]
Awad, S.F.; Critchley, J.A.; Abu-Raddad, L.J. Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictions. Epidemics, 2019, 30, 100381.
[http://dx.doi.org/10.1016/j.epidem.2019.100381] [PMID: 31846721]
[76]
World Health Organization.Consolidated guidelines on tuberculosis. Module 1: prevention - tuberculosis preventive treatment; Geneva, 2020.
[77]
Quist-Therson, R.; Kuupiel, D.; Hlongwana, K. Mapping evidence on the implementation of the WHO’s collaborative framework for the management of tuberculosis and diabetes: a scoping review protocol. BMJ Open, 2020, 10(1), e033341.
[http://dx.doi.org/10.1136/bmjopen-2019-033341] [PMID: 31969365]

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy